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Development of kidney tubular basement membranes
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Kidney basement membranes serve several critical functions.
First, the glomerular basement membrane (GBM) and tubular
basement membrane (TBM) are adhesive substrates that anchor
the basal plasma membranes of attached cells. In the glomeru-
lus, endothelial cells are attached to the innermost or vascular
surface of the peripheral loop GBM, whereas the podocytes are
attached to the opposite, outer surface. This unique arrange-
ment is due, at least in part, to the apparent fusion of a thin
basement membrane beneath immature endothelial cells with a
somewhat thicker basement membrane beneath developing
podocytes during initial formation of the glomerular capillary
wall [reviewed in 11. Throughout the rest of the nephron, tubule
epithelial cells are attached to the TBM that overlies the
subjacent interstitial connective tissue. The disruption of cell-
basement membrane adhesion results in loss of cell orientation,
abnormal cell function, and can lead to tissue destruction.
The second important role played by kidney basement mem-
branes involves the well-established permselective barrier
properties of the GBM [reviewed in 2 and 3]. These barrier
properties are undoubtedly not limited to the GBM, however,
and the TBM probably also restricts to some extent the bidi-
rectional passage of macromolecules between the tubule and
interstitium. Abnormalities in basement membrane stucture
occurring as a result of inflammatory damage, or due to changes
in biosynthesis and turnover, would clearly affect the abilities of
the GBM and TBM to establish functional barriers.
A third important function for basement membranes is linked
to the first two and deals with the crucial role played by the
extracellular matrix in embryonic development and organogen-
esis [reviewed in 4 and 51. Once again, errors in basement
membrane structure can clearly affect normal tissue develop-
ment and repair. This article will summarize some of the current
information regarding basement membrane structure and mech-
anisms for assembly during nephrogenesis, paying particular
attention to development of the TBM.
Biochemical composition of basement membranes
A number of detailed reviews covering basement membrane
structure, biochemistry, and biological properties have been
published in the past few years [6—14]. In addition, separate
reviews on each of the major basement membrane components
including collagen type IV [15, 16], laminin [17], and proteogly-
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cans [18—201 have appeared. The next several paragraphs are
meant to provide only a brief summary on what is known about
basement membrane structure but this will form the basis for
the balance of the discussion on development of the TBM.
When examined in the electron microscope, the TBM con-
sists of two distinct layers termed the lamina densa, which is
electron dense, and the lamina rara or lucida, which is electron
lucent (Fig. 1). The thickness of the TBM varies with location
along the length of the mature nephron. The TBM beneath the
proximal tubule is the thickest, measuring approximately 100
nm in rats while the TBMs of the ioop of Henle and distal
segment are thinner, measuring less than 80 nm. High resolu-
tion electron microscopic images show that the TBM and all
other basement membranes are composed of a meshwork of
fine 3 to 8 nm thick fibrils, which are referred to by others as
"cords" [13, 14, 21, 22]. The cords are concentrated in the
lamina densa, and others, which are oriented in a plane that is
perpendicular to the lamina densa, cross the lamina lucida to
join the basal plasmalemmae of attached cells (Fig. 1).
Basement membranes are generally insoluble and the isola-
tion of individual components for biochemical analysis has
therefore been difficult. Much of the current information regard-
ing basement membrane biochemistry stems from key studies
carried out several years ago on relatively easily obtained
basement membranes, such as those from lens capsule [23, 24]
and Reichert's membrane [25, 26]. In addition, experiments
with rodent neoplasms that secrete basement membrane-like
matrices, such as the murine Englebreth-Hoim-Swarm (EHS)
tumor [27, 28] and parietal yolk sac carcinoma [29], have been
particularly useful since comparatively large amounts of mate-
rial can be obtained.
Current estimates are that 50% or more of the total protein
content of basement membranes is collagen [10] and nearly all
of this is type IV. Type IV collagen [Mr —550,000] is composed
of three polypeptides of two different s-chains, [al(IV)]2 and
c2(IV)] assembled into a triple helix [reviewed in 8, 10, 11, 12,
15, 16]. Additional collagen IV chains (x3, a4, aS) are likely
also present in certain basement membranes, especially the
GBM [16]. Disulfide rich domains occur at both the amino and
carboxy termini of the al and a2 chains of collagen type IV.
Covalent binding between separate amino terminal domains of
neighboring type IV molecules develops and crosslinking be-
tween separate carboxy termini also takes place. These inter-
actions have been shown by rotary shadowing and electron
microscopy to generate a network of polymerized type IV
collagen [30]. In addition to the cross linking at separate amino
and carboxy termini, lateral interactions between triple helical
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Fig. 1. Electron micrograph showing portion of developing tabale and adjacent interstitiam from newborn rat kidney. a. A linear tubular basement
membrane (TBM) is seen at the base of tubular epithelial cell (Ep). IF: interstitial fibroblasts. Arrowhead points to region shown at higher
magnification in b. x 18,500. b. Lamina densa (Id) and lamina rara (Ir) of the TBM is shown. Note additional layers of basement membrane-like
material in areas adjacent to the TBM (arrows). x 38,000.
domains of individual type IV molecules may likewise take sites distributed along the length of the helix, and this can
place, producing an extended meshwork [31]. In addition, the produce a polygonal latticework of collagen IV [32]. Most
carboxy terminal domain has also been shown to bind to several evidence indicates that the other major components of base-
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ment membranes are attached to, and embedded within, this
collagen IV superstructure.
Laminin [Mr —850,000] is the major noncollagenous glyco-
protein of basement membranes. EHS tumor laminin consists
of three separate polypeptide chains designated A, Bi, and B2
linked by disulfide bonds to form an asymmetric 4-armed
cross-shaped structure as visualized by electron microscopy
[331. Current models for laminin predict that each polypeptide
chain forms one short arm and that all three chains are joined by
disulfide bonds to form the long arm [341. Several studies have
clearly shown that a number of different cells bind laminin in
vitro, and one of its major functions in vivo therefore seems to
be to mediate cell attachment to basement membranes [re-
viewed in 6—8, 10—12, 17]. In addition to binding to cells,
however, laminin also binds to collagen type IV and heparan
sulfate proteoglycan [6—8, 10—12, 17]. Laminin also self-associ-
ates at 35°C through interactions between the terminal globular
domains of the molecule [35]. Some specific structural domains
for binding have been identified; the terminal globular ends of
both the long and short arms bind type IV collagen [361, and the
end of the long arm binds heparan sulfate proteoglycan [37].
The end of the long arm has also been identified as a potent
promoter of neurite outgrowth in vitro and to contain cell
binding activities [reviewed in 6—8, 10—12, 171.
Heparan sulfate proteoglycan (HSPG) occurs as a small, high
density form and a large, protein-rich low density form. The
high density form [Mr —130,000] is found in the EHS tumor and
the GBM [38]. This form has four heparan sulfate chains
attached to a core protein [Mr ——5,000—18,000]. The low density
form [Mr --600,000] is also found in the EHS tumor [39] and has
three heparan sulfate chains joined to a large core protein [Mr
—-500,000]. Current reports are that the smaller GBM proteo-
glycan is derived proteolyticaly from the larger form [401. These
proteoglycans contain abundant polyanionic charges due to the
presence of sulfate as well as carboxyl groups. Thus, they likely
play a major role as a charge barrier in filtration of molecules
across the GBM [2, 3]. As mentioned above, HSPG binds to the
end of the long arm of laminin [37] and also to the amino and
carboxy termini of collagen type IV [41]. Chondroitin sulfate
proteoglycans (CSPG) are also present in kidney basement
membranes [2, 3]. Recently, a CSPG with a core protein of Mr
—160,000 has been immunolocalized with monoclonal antibod-
ies to the mesangial matrix, Bowman's capsule, and TBM of
mature rat kidney [42]. The function of this class of proteogly-
cans in basement membranes is currently unknown.
Other components of basement membranes include entactin!
nidogen and fibronectin. Entactin [43], is a sulfated glycopro-
tein (Mr —150,000) shown by immunolocalization techniques to
be present in kidney basement membranes. Nidogen [44], a
protein characterized from the EHS tumor, is virtually identical
to entactin on the basis of amino acid sequences derived from
cDNA clones for each protein [45, 46]. Nidogen is composed of
a single polypeptide chain that folds into two globular domains
of —38 and ——85 kD connected by a 17 nm long rod [47, 48].
Nidogen forms a stable, non-covalent complex with laminin [48]
and also binds to the NCI domain of collagen type IV [17, 49].
Fibronectin [M4 440,000] is a V-shaped protein measuring 60
nm [33] composed of two similar polypeptide chains joined near
their carboxy termini via disulfide bonds. Each chain consists of
a series of globular domains that are specialized for binding
other ligands; specific domains have been identified that bind
collagen (types I, II, III, IV, and V), fibrin, heparin, and some
cells [50, 51]. Since plasma fibronectin has slight structural
differences from the cellular form, there is debate whether
fibronectin is an intrinsic component of basement membranes
or an extrinsic plasma component that simply becomes trapped
in basement membranes [1, 6]. Nevertheless, particularly large
amounts of fibronectin can be immunolocalized in basement
membranes during tissue development.
Although some of the major structural components have been
identified, the complete molecular composition of basement
membranes remains unclear and there likely are many more
components yet to be characterized.
General molecular architecture of basement membranes
Several general structural models for basement membranes
have been proposed in the past few years [13, 14, 52, 53]. These
models have developed from experiments whereby mixtures of
basement membrane components are rotary shadowed with
platinum and examined by electron microscopy. Much addi-
tional information has come from numerous immunoelectron
microscopic studies on a wide variety of basement membranes
from different tissues. There is now near universal agreement
that all of the well characterized components are present within
both the lamina lucida and densa of basement membranes,
including the TBM. Exactly what spatial arrangement each
molecule assumes in vivo with respect to itself or to other
basement membrane proteins has not been established, how-
ever. The evidence indicates, nonetheless, that a three dimen-
sional meshwork of polymerized type IV collagen forms the
superstructure upon which the other basement membrane com-
ponents are configured.
Basement membrane heterogeneity
Recent evidence has accumulated showing that different
basement membranes are structurally, and probably composi-
tionally, heterogeneous [7, 8, 54]. For example, some anti-
human basement membrane monoclonal antibodies were shown
to react only with certain epitheliat basement membranes by
immunofluorescence microscopy [55]. Furthermore, a mono-
clonal antibody against collagen type IV was found to label only
the mesangial matrix and subendothelium of human GBM
whereas polyclonal anti-type IV labels the entire GBM [56].
Some polyclonal anti-HSPG antibodies, which stain almost all
epithelial basement membranes, fail to recognize most smooth
muscle basement membranes [57]. In addition, two rat anti-
mouse laminin B chain monoclonal antibodies produce different
labeling patterns on various mouse basement membranes [58].
On sections of mouse kidney, one of these anti-laminin mono-
clonals binds to all renal basement membranes whereas the
other reacts only with the proximal TBM and the basement
membrane of Henle's loop 159]. A separate set of three rat
anti-mouse laminin monoclonal antibodies show a similar vari-
ability in binding mouse GBM and TBM by immunofluores-
cence microscopy [60]. An immunoelectron microscopic study
with yet a third group of rat anti-mouse laminin monoclonals
shows that epitopes at the end of the long arm are uniquely
immunoreactive within the lamina rara of Bowman's capsule
and proximal TBM, but the laminae densae in these same
basement membranes are unreactive [61]. In contrast, the end
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of the long arm can be immunolocalized in both the lamina rara
and densa of distal TBM [61]. Still other immunoultrastructural
patterns are seen with anti-laminin monoclonals directed
against the short arms near the center of cross. These bind to
discrete spots scattered across the full width of Bowman's
capsule and proximal TBM but in a dense, essentially linear
fashion across the distal TBM [61]. A major conclusion drawn
from these studies is that the packaging or integration of laminin
into different basement membranes varies. In addition, there
may be structurally distinct isoforms of laminin present within
different basement membranes. Indeed, a recently identified
isoform of laminin, termed s-laminin, is particularly enriched in
the GBM and synaptic sites in muscle [62]. Finally, two
independently conducted studies using polyclonal antibodies
against laminin, type IV collagen, and HSPG concluded on the
basis of quantitative immunogold cytochemistry that the rela-
tive amounts of these basement membrane components vary in
different sites [63, 64].
That separate layers or planes within basement membranes
are organized differently has been known for some time.
Histochemical labeling studies with cationic probes, such as
ruthenium red, alcian blue, and cationized ferritin, show a
concentration of anionic sites in the lamina rara and a general
absence of negative charge in the lamina densa [reviewed in 2].
Pretreatment of basement membranes with heparatinase abol-
ishes labeling in the lamina rara, strongly suggesting that the
negative charges seen in this location are due mostly to the
presence of heparan sulfate glycosaminoglycans [2]. Some
earlier immunoelectron microscopic labeling studies also sug-
gested a stratified organization of basement membranes, with
laminin and HSPG occupying the lamina rara exclusively, and
collagen type IV residing only in the lamina densa [2]. As
discussed previously, however, most of the current evidence
indicates that all layers of basement membranes contain all of
the known basement membrane macromolecules. The picture
that now emerges from monoclonal immunolocalization exper-
iments is that the various basement membrane components may
assume different spatial arrays within different planes of the
basement membrane. Further, there are likely to be specialized
isoforms that are found only in certain locations and only at
certain times during development.
Basement membrane biosynthesis
Most evidence indicates that cells synthesize basement mem-
brane components [65, 66], deposit these extracellularly, and
use the resulting matrix as a substrate during tissue develop-
ment [67]. However, the factors regulating biosynthesis and
assembly of a histologically recognizable basement membrane
are generally unknown. Immunoelectron microscopic localiza-
tion studies demonstrate that basement membrane precursors
can be identified in developing tissues within the rough endo-
plasmic reticulum, Golgi apparatus, and what are believed to be
secretory organelles of the common protein transport pathway
[68—71]. Presumably these proteins are secreted by the usual
exocytic mechanisms into the extracellular space, but only a
few electron microscopic profiles documenting exocytosis of
basement membrane components by cells in normal, develop-
ing tissues have been illustrated [69].
The synthesis of different basement membrane molecules
clearly varies with different stages of embryogenesis and orga-
nogenesis. For example, laminin, HSPG, and entactin appear
on the cell surface of developing mouse blastocysts prior to
type IV collagen [49, 72—74]. Laniinin and HSPG seem to be the
first basement membrane proteins synthesized and have been
detected by immunofluorescence microscopy in small patches
on the cell surfaces of two-cell stage mouse embryos 149, 74].
The initiation of synthesis of the laminin A and B chains is
apparently not synchronous, however. Immunoprecipitation
experiments have shown that the laminin B! and B2 chains are
present in 4- and 8-cell stage embryos whereas the A chain is
not detectable until the 16-cell stage [75]. Similarly, Entactin/
nidogen is first detected in 8- or 16-cell stage morulae [74].
Several lines of evidence indicate that once basement mem-
brane protein synthesis has begun, the complete assembly of
the matrix takes place extracellularly rather than intracellularly.
First, structures that morphologically resemble intact basement
membrane segments are ordinarily not recognized within cyto-
plasmic organelles in developing tissues. Second, in vitro
reconstitution experiments have shown that type IV collagen
and laminin, when present together, potentiate the precipitation
of each other and the precipitation is maximal when small
amounts of HSPG are added [761. Third, electron microscopic
examination of some of the aggregates that form in these in vitro
reconstitution experiments show the presence of structures that
appear similar to the lamina densa of genuine basement mem-
branes [14, 771.
The findings that mixtures of basement membrane proteins
can apparently form ultrastructural equivalents of basement
membranes in vitro, yet these structures are not seen intracel-
lularly, are intriguing since they suggest that the separate
components are segregated within distinct intracellular com-
partments in the biosynthetic pathway. Alternatively, intracel-
lular interactions between the separate components may be
inhibited by accessory peptides that are removed only after
secretion. An additional possibility is that the individual base-
ment membrane components are products of separate cells.
Perhaps all three possibilities can occur.
Role of basement membranes in morphogenesis
The mechanisms governing the development of three-dimen-
sional form are almost totally obscure, especially when one
considers the spatial complexity of the epithelial as well as
vascular elements of the nephron. As will be discussed below,
however, there are marked changes that occur within kidney
basement membranes that correspond with particular morpho-
genetic events. How can extracellular matrices influence devel-
opment? Recent experiments have shown that a class of hep-
arm-binding angiogenic factors, which are related to fibroblast
growth factor, are associated with corneal basement mem-
branes [78]. Conceivably, the concentration within tissues of
these angiogenic factors, and perhaps other growth factors,
could be regulated by the release of these basement membrane-
bound factors into the local environment [78]. Other studies
have shown that the RGD tripeptide in the laminin A chain
mediates endothelial cell attachment in vitro [79]. Once these
cells are attached, the YIGSR pentapeptide on the laminin BI
chain then stimulates morphogenesis and endothelial tube for-
mation [79]. A number of other experiments with cultured cells
have convincingly demonstrated that these peptides and other
extracellular proteins affect cell behavior and morphology by
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binding to cell surface receptor proteins [reviewed in 7, 8,10—12,
80—82]. The specific association of these receptors with extra-
cellular matrix is then conveyed via the cytoskeleton to regu-
latory elements within the cell. These mechanisms likely also
operate in vivo, but the precision and spatial specificity with
which they occur during morphogenesis are difficult to compre-
hend.
Kidney basement membrane assembly mechanisms during
development
Several aspects of nephrogenesis in the mammalian meta-
nephric kidney have recently been reviewed [1,4, 5, 83, 84]. In
brief, a branching uretic bud grows into the forming renal cortex
and sequentially induces the conversion of groups of nephro-
genic mesenchymal cells into an epithelial phenotype. Each
group of induced cells then undergoes morphogenesis giving
rise to a nephron. Although the precise inductive mechanism
for this mesenchyme-epithelium switch is not understood,
growth factors originating from the uretic bud are believed to be
critically important in triggering determination and differentia-
tion [1, 4, 5, 83, 84]. Which growth factors are involved, and at
which stages, will undoubtedly become the topic of intense
research activity in the near future.
Immunofluorescence studies with transfilter organ cultures of
mouse nephrogenic mesenchyme have shown that small
amounts of laminin B chains are produced by undifferentiated
mesenchymal cells before induction [85]. The A chain is not
detectable, however, until epithelial conversion and polariza-
tion of the nephrogenic cells [85], which also corresponds to the
appearance of an intact basement membrane containing colla-
gen type IV and HSPG [86—911. The abrupt appearance of
laminin A chain only upon epithelial conversion has also been
seen in chimeras obtained by culturing mouse kidney rudiments
on chick chorioallantoic membranes [92]. In addition, the
presence of the A chain seems critically important for estab-
lishing epithelial polarity, since A chain-specific antisera block
polarization in transfilter organ cultures [85].
Once epithelial conversion has been induced, rapid mitotic
activity and cell differentiation establish the visceral and pan-
etal epithelium of Bowman's capsule and the renal tubule.
Tubulogenesis actually starts in a region of the growing nephron
that inserts into the uretic bud (which will develop into the
collecting system) and progresses proximally towards the gb-
merulus [93]. Glomerulogenesis and tubulogenesis are accom-
panied by a burst in basement membrane protein biosynthesis
that is needed as substrate for epithelial cells in the rapidly
growing nephron. Northern analysis of total RNA obtained
from embryonic day-16 mouse kidneys has shown the presence
of RNA coding for laminin B chains and the al chain of collagen
type IV [94]. Laminin A chain mRNA was not detected on
Northern blots from RNA obtained from neonatal kidneys in
this study, however [94]. In situ hybridization has revealed that,
in general, collagen type IV and laminin BI and B2, as well as
laminin A chain RNAs reach peak levels in glomeruli at birth
and decline to essentially background levels three weeks later
[94, 95]. In contrast, the highest levels of basement membrane
protein RNA expression in tubules and ducts are observed one
to two weeks after birth [94, 951. These peaks tubule levels seen
in the young mouse also subside after three weeks, which
corresponds to the time when tubule elongation is apparently
complete.
To determine which tubular cells are actually synthesizing
laminin protein, kidneys from two-day-old rats were lightly
fixed and sections were bathed with sheep anti-laminin IgG
coupled to horseradish peroxidase, as described previously
[701. Once tissue was processed histochemically for peroxidase
activity and examined by electron microscopy, we observed
reaction product intracellularly within biosynthetic organelles
as well as extracellularly within basement membranes (Fig. 2).
In addition to finding laminin immunoreactivity within cytoplas-
mic organelles of tubule epithelial cells, however, intracellular
reaction product was also identified within cells resembling
fibroblasts in the tubular interstitium (Fig. 2). In addition to
synthesizing the fibrillar collagens, fibronectin, and proteogly-
cans of the interstitial extracellular matrix, these fibroblasts are
therefore also involved in basement membrane laminin synthe-
sis.
Whether the laminin-positive interstitial fibroblasts are syn-
thesizing laminin that will be assembled into the TBM or
possibly also into the subendothelial basement membranes of
developing peritubular capillaries is not presently known. Nev-
ertheless, there are precedents for the participation of different
cell types in the joint formation of basement membranes. For
example, the use of species-specific anti-collagen type IV
antibodies and combination cultures of quail myoblasts and
mouse fibroblasts showed that collagen derived from both cell
types is deposited in the basement membranes that form around
myotubes [96]. Similar studies have also shown that the addi-
tion of fibroblasts into cultures of cloned quail myoblasts
maintained in collagen gels is actually required in order to form
an intact muscle basement membrane [971. Additional experi-
ments involving the coculture of epithelial cell lines with
fibroblasts also resulted in the production of a network of
basement membrane proteins [98].
in the kidney, considerable evidence exists for the joint
participation of glomerular endothelial and epithelial cells in
production of the GBM. Perhaps the earliest proposal that both
cell types are involved in GBM biosynthesis was made nearly
30 years ago on the basis of electron microscopic findings in
fetal human kidneys of a double lamina densa between the
endothelium and podocytes [99]. The observation of a dual
basement membrane in developing glomerular capillary walls
has since been confirmed in a number of additional studies [1, 7,
70, 100—105] and the concept has emerged that the two base-
ment membranes "fuse" giving rise to the GBM. Additional
support for this fusion concept has come from studies where
avascular, embryonic mouse kidney rudiments are grafted onto
chick chorioallantoic membrane [1061. In this case, vessels
stemming from the chick embryo vascularize the graft and
apparently also establish the glomerular endothelium [107]. The
use of species-specific anti-collagen type IV antibodies has
shown that the GBMs that form in the grafts contain collagen of
both mouse and chick origin [106]. Direct evidence for laminin
biosynthesis by both the glomerular endothelium and develop-
ing podocytes has come from immunoelectron microscopic
studies of newborn rat kidney [70]. Immunoreactive laminin can
be localized to the rough endoplasmic reticulum and Golgi
apparatus in both cell types, as well as to the intervening double
basement membrane [701.
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Fig. 2. Electron micrograph of newborn rat kidney. Tissue was fixed in 2% paraformaldehyde and sections were bathed in peroxidase-anti-laminin
IgG conjugates. Dense peroxidase reaction product is seen in the TBM. In addition numerous biosynthetic organelles within the tubular epithelium
(Ep) and interstitial fibroblasts (IF) are also immunoreactive for laminin (arrows). x 12,000.
Although the endothelium and epithelium jointly synthesize brane observed beneath the developing endothelium appears
elements of the GBM, there are indications that they do not thinner than that seen beneath the podocytes [11. Secondly, as
participate equally in this process. First, the basement mem- glomeruli mature, bulk basement membrane biosynthesis by the
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Fig. 3. Light micro graphs showing the distribution of bound anti-laminin-IgG-peroxidase conjugates 2 hours after intravenous injection into 2-day
old rats (a and b) and 4 days after injection (c). All GBMs and TBMs are densely labeled at 2 hours (a and b). In contrast, large segments of
unlabeled basement membrane are seen at 4 days (c). Some glomerular loops are labeled (large arrows), but some are not (small arrows). Similarly,
lengths of labeled TBM (large arrowheads) and unlabeled TBM (small arrowheads) are seen, a x 400, b x 500, c x 400.
endothelium seems to greatly diminish, if not cease entirely,
whereas basement membrane formation by the podocytes con-
tinues until the glomerulus is fully formed [70, 1041. In vivo
immunocytochemical labeling studies have shown that the
newly assembled GBM from the podocytes is spliced into the
existing, fused GBM during capillary loop expansion [70, 104].
A similar process of splicing new basement membrane into old
also occurs in developing endocrine organs [71, 1081 and along
the basement membranes beneath the absorptive epithelium in
the small intestine [109].
To determine whether the TBM might also be assembled by
splicing newly synthesized basement membrane into that al-
ready present, we examined kidneys from newborn rats that
had received intravenous injections with peroxidase conjugated
anti-laminin IgG [70]. As described before [70], when kidneys
were fixed two to three hours after anti-laminin injection, all
GBMs and TBMs were labeled with peroxidase reaction prod-
uct in a linear pattern and this is shown by light microscopy in
Figures 3a and b. In contrast, when kidneys were fixed four
days after injection, many glomerular capillary loops were
incompletely labeled, or not labeled at all (Fig. 3c). Similarly,
irregular labeling was also seen in the TBM, and many tubules
were totally unlabeled (Fig. 3c). These unlabeled GBMs and
TBMs undoubtedly represent lengths of basement membrane
that were not present four days earlier when the intravenous
injection of anti-laminin was given [70, 104]. Corresponding to
the light microscopic findings, electron microscopy showed
lengths of weakly labeled or unlabeled TBM interspersed
between lengths containing dense anti-laminin IgG-peroxidase
reaction product (Fig. 4). Overall, these results from studies on
the developing TBM are strikingly similar to those obtained
previously in other basement membranes [71, 108, 109]. Taken
together, the evidence indicates that much of these basement
membranes are assembled by the progressive insertion or
splicing of new matrix into old. The strands of basement
membrane-like material seen in areas beneath the developing
TBM (Fig. 1) may represent segments of new TBM that are
becoming associated with that already present.
Kidney basement membrane turnover
As is the case with the GBM, the molecular details regarding
splicing in the TBM are totally lacking. In addition, once the
kidney is fully developed, the mechanisms for basement mem-
brane turnover and remodeling with ageing are not known.
Studies carried out by labeling rat GBM in vivo with the
addition of silver nitrate to drinking water have shown that
labeled GBM persists for months after the silver nitrate is
withdrawn [1101. Essentially similar findings showing an appar-
ently slow rate of turnover are observed after in vivo labeling
with intravenous injections of anti-laminin IgG into adult rats
[111]. Amino acid labeling studies also demonstrate a slow rate
of GBM collagen turnover [112]. Presumably, the podocytes are
h
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Fig. 4. Electron micrograph showing developing renal tubules from a 6-day-old rat that received an intravenous injection of peroxidase
conjugated to anti-laminin IgG at 2 days of age. Areas of densely labeled TBM (arrows) are interspersed with unlabeled lengths (arrowheads). The
unlabeled TBM was most likely assembled during the interval between day 2 and 6 and spliced into the labeled TBM. R: reticulocyte, En:
endothelium of peritubular capillary, IF: interstitial fibroblast, Ep: tubule epithelium. x 10,000.
largely responsible for continued GBM collagen and laminin
biosynthesis in adults, albeit at only relatively low levels,
although the endothelium may also participate to some degree
in this process. In contrast to collagen and laminin, the turnover
of GBM proteoglycan glycosaminoglycans appears to be much
more rapid and estimates of the half-life of GBM heparan
sulfate are on the order of a few days [911. Even less is known
about the fate of TBM proteins, and none of the kidney
basement membrane turnover studies discussed here specifi-
cally addressed the issue of TBM turnover.
Disorders resulting from abnormal TBM development and/or
turnover
Much additional basic information is clearly needed to under-
stand how the TBM is assembled during normal development.
This understanding is especially important clinically, since
there is an accumulating body of recent evidence that points to
errors in basement membrane assembly and/or turnover as
central defects in several serious tubulointerstitial disorders,
including hereditary cystic kidney diseases [113]. For example,
a number of striking ultrastructural alterations have been iden-
tified in TBMs of patients with nephronophthisis-medullary
cystic disease [114]. These abnormalities affect all lengths of the
nephron and range from extreme thinning of the TBM to
extreme thickening and multilamination [114]. The focal ab-
sence of staining with anti-TBM autoantibody seen in these
patients is also reminiscent of an absence of staining with
Goodpasture's autoantibody in the GBM of Alport's patients
[16, 115] and further reflects abnormal basement membrane
structure.
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Adult polycystic kidney disease (PKD) is n autosomal dom-
inant condition that is among the most common of all heritable
diseases in humans [113, 116]. PKD is characterized by the
progressive formation of large tubular cysts that can be located
anywhere along the length of the nephron and these typically
lead to renal failure by mid-life. Although the precise genetic
defect of PKD is undefined at this time, some studies have
suggested that cysts develop as a result of a failure in tubular
transport processes or to tubular epithelial hyperplasia. More
recently, several observations in humans and in animal models
of PKD have documented distinct TBM abnormalities strongly
suggesting that basement membrane defects may be the primary
pathogenic component in PKD. Immunofluorescence studies on
kidney sections from PKD patients have shown a marked
reduction in immunoreactive HSPG when compared to what is
seen in the TBM of normal controls [1171. This apparent
decrease in HSPG is accompanied by massive and diffuse
increases in interstitial fibronectin [117]. Parallel findings re-
garding the loss of HSPG from the TBM also occur in an
experimental model of PKD obtained by treating rats with
diphenylthiazole or its derivatives, indicating an error in regu-
lation of basement membrane biosynthesis or turnover [117—
119].
Autosomal recessive polycystic kidney disease occurs less
frequently in humans than the dominant form of PKD and
generally results in death during infancy. A mouse genetic
model for recessive PKD has been developed IC57BL/6J-cpkl
cpk] [120—122], and two separate morphologic phases in the
disease have been described [123]. In the first phase, developing
proximal tubules are dilated, tubular mitotic indices are ele-
vated, and proximal TBM thickening is observed in fetal and
newborn mice homozygous for the trait [123]. In the second
phase, which occurs one to three weeks after birth, overall
kidney size and cyst dimension increase enormously but this is
not accompanied by marked epithelial hyperplasia [123]. In
addition, abnormal amounts of mRNA for the c1 chain of type
IV collagen and the laminin Bi and B2 chains are detected on
dot blots of total RNA extracted from newborns, indicating
defective basement membrane gene expression during nephro-
genesis in the cystic kidneys [124].
Other disorders associated with possible abnormalities in
TBM structure, development, or turnover include diabetes. In
diabetes mellitus, which is a chronic illness characterized by
inadequate peripheral action of insulin with fasting hyperglyce-
mia and glycosuria, widespread thickening of basement mem-
branes is found in multiple organs. In the diabetic kidney, much
attention has been paid to the thickened GBM, but the TBM is
usually also thickened. GBM thickening has been shown to be
associated with an increase in type IV collagen and laminin
components and a decrease in heparan sulfate proteoglycan
[125, 126]. Whether the observed thickening is a consequence
of abnormal carbohydrate metabolism, compensatory hyperse-
cretion of basement membrane components, or abnormal base-
ment membrane turnover remains unclear.
Summary
Although some progress has been made in recent years, there
are truly large gaps in our basic knowledge on how the TBM is
assembled during development. Some of the new evidence
presented here indicates that both the tubular epithelium and
interstitial fibroblasts participate in TBM protein biosynthesis
during nephrogenesis. In addition, newly assembled segments
of TBM are spliced or inserted into existing TBM during tubule
expansion and elongation. A similar splicing mechanism has
been described previously in the GBM, endocrine organs, and
intestinal villi, and this mechanism therefore probably repre-
sents a fundamental process of basement membrane formation.
A major unresolved question at present, however, is how this
mechanism operates at the molecular level. Does the newly
formed basement membrane contain identical components as
that already present? Since an enzymatic process is likely
ocduring in the insertion of new matrix into old, which enzymes
are involved? What is the cellular origin of these enzymes and
which matrix component(s) is their substrate? Even more
fundamental yet unanswered questions have to do with the
mechanisms of epithelial induction, basement membrane gene
activation, and tubular morphogenesis. Once the basement
membrane is fully formed at the completion of nephrogenesis,
what controls basement membrane turnover and how does this
operate? Clearly, much additional research is necessary to
address these questions. This work is needed, however, before
we can fully understand the important roles basement mem-
branes play in normal development as well as in disease.
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